Literature DB >> 27527818

Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies.

Ryan M Close1, Catherine Pearson2, Jennifer Cohn3.   

Abstract

Complex humanitarian emergencies affect 40-60 million people annually and are a growing public health concern worldwide. Despite efforts to provide medical and public health services to populations affected by complex emergencies, significant morbidity and mortality persist. Measles is a major communicable disease threat, but through vaccination of broader target age groups beyond the traditional immunization schedule, measles-related mortality has been significantly reduced during crises. Yet, a limited number of vaccine-preventable diseases continue to contribute disproportionately to morbidity and mortality in complex emergencies. The literature suggests that Streptococcus pneumoniae, Rotavirus, and Haemophilus influenzae type-b should be key targets for vaccination programs. Because of the significant contribution of these three pathogens to complex humanitarian emergencies in low and middle-income countries regardless of disaster type, geography, or population, their vaccines should be considered essential components of the standard emergency response effort. We discuss the barriers to vaccine distribution and provide evidence for strategies to improve distribution, including expanded target age-range and reduced dose schedules. Our review includes specific recommendations for the expanded use of these three vaccines in complex emergencies in low and middle-income countries as a way to guide future policy discussions.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complex emergency; Epidemiology; Humanitarian crisis; Vaccination; Vaccine-preventable disease

Mesh:

Substances:

Year:  2016        PMID: 27527818     DOI: 10.1016/j.vaccine.2016.08.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Strengthening vaccination delivery system resilience in the context of protracted humanitarian crisis: a realist-informed systematic review.

Authors:  Sharif A Ismail; Sze Tung Lam; Sadie Bell; Fouad M Fouad; Karl Blanchet; Josephine Borghi
Journal:  BMC Health Serv Res       Date:  2022-10-23       Impact factor: 2.908

2.  Challenges in Estimating Vaccine Coverage in Refugee and Displaced Populations: Results From Household Surveys in Jordan and Lebanon.

Authors:  Timothy Roberton; William Weiss; Shannon Doocy
Journal:  Vaccines (Basel)       Date:  2017-08-12

3.  The effect of the ongoing civil strife on key immunisation outcomes in the North West and South West regions of Cameroon.

Authors:  Yauba Saidu; Marius Vouking; Andreas Ateke Njoh; Hassan Ben Bachire; Calvin Tonga; Roberts Mofor; Christain Bayiha; Leonard Ewane; Chebo Cornelius; Ndi Daniel Daddy Mbida; Messang Blandine Abizou; Victor Mbome Njie; Divine Nzuobontane
Journal:  Confl Health       Date:  2021-02-10       Impact factor: 2.723

4.  IMMUNOGENICITY AND IMPACT ON NASOPHARYNGEAL CARRIAGE OF A SINGLE DOSE OF PCV10 GIVEN TO VIETNAMESE CHILDREN AT 18 MONTHS OF AGE.

Authors:  Rachel A Higgins; Beth Temple; Vo Thi Trang Dai; Thanh V Phan; Nguyen Trong Toan; Leena Spry; Zheng Quan Toh; Monica L Nation; Belinda D Ortika; Doan Y Uyen; Yin Bun Cheung; Cattram D Nguyen; Kathryn Bright; Jason Hinds; Anne Balloch; Heidi Smith-Vaughan; Tran Ngoc Huu; Kim Mulholland; Catherine Satzke; Paul V Licciardi
Journal:  Lancet Reg Health West Pac       Date:  2021-09-20

5.  Measles in conflict-affected northern Syria: results from an ongoing outbreak surveillance program.

Authors:  Sammy Mehtar; Naser AlMhawish; Kasim Shobak; Art Reingold; Debarati Guha-Sapir; Rohini J Haar
Journal:  Confl Health       Date:  2021-12-21       Impact factor: 2.723

6.  Risk factors and risk factor cascades for communicable disease outbreaks in complex humanitarian emergencies: a qualitative systematic review.

Authors:  Charlotte Christiane Hammer; Julii Brainard; Paul R Hunter
Journal:  BMJ Glob Health       Date:  2018-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.